HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma
K. Humphrey, Katherine J. Crawford, Bharani Muppavarapu, Melanie M. Mayberry et autres
0 citationsCommunications Biology
Agnieszka K. Witkiewicz
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
462Publications signalées
20192Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Advanced Breast Cancer TherapiesCancer-related Molecular PathwaysPancreatic and Hepatic Oncology ResearchCancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics
Publications récentes
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor–Resistant HR+/HER2− Breast Cancer
Dejan Juric, Kazi Nazrul Islam, Ioanna‐Maria Gkotinakou, A. Zheng et autres
0 citationsCancer Research
Figure S6 from Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222
Adam P. Dommer, Vishnu Kumarasamy, Jianxin Wang, Thomas N. O’Connor et autres
0 citations
Supplementary Table S1 from Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models
Jin Wu, Jianxin Wang, Thomas N. O’Connor, Stephanie L. Tzetzo et autres
0 citations
Supplementary Table S4 from Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models
Jin Wu, Jianxin Wang, Thomas N. O’Connor, Stephanie L. Tzetzo et autres
0 citations
Supplementary Figure S4 from Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models
Jin Wu, Jianxin Wang, Thomas N. O’Connor, Stephanie L. Tzetzo et autres
0 citations
Supplementary Table S2 from Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models
Jin Wu, Jianxin Wang, Thomas N. O’Connor, Stephanie L. Tzetzo et autres
0 citations
Supplementary Figure S5 from Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models
Jin Wu, Jianxin Wang, Thomas N. O’Connor, Stephanie L. Tzetzo et autres
0 citations
Supplementary Figure S2 from Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models
Jin Wu, Jianxin Wang, Thomas N. O’Connor, Stephanie L. Tzetzo et autres
0 citations
Figure S3 from Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222
Adam P. Dommer, Vishnu Kumarasamy, Jianxin Wang, Thomas N. O’Connor et autres
0 citations
Supplementary Figure S6 from Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models
Jin Wu, Jianxin Wang, Thomas N. O’Connor, Stephanie L. Tzetzo et autres
0 citations
Figure S2 from Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222
Adam P. Dommer, Vishnu Kumarasamy, Jianxin Wang, Thomas N. O’Connor et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.